ERBB2 and cancer: Moreover, we found that compared to HER2-negative cancers, HER2-positive cancers were larger and exhibited more aggressive imaging features, including multifocal lesions, intratumoral and peritumoral edema, ipsilateral vascularity increase, lymphadenectasis, and other accompanying signs, which is consistent with the results of Zhou et al. (2025).